StemCyte International, Ltd. (TPEX:4178)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
27.10
+0.50 (1.88%)
At close: Mar 6, 2026

StemCyte International Revenue

StemCyte International had revenue of 197.31M TWD in the half year ending June 30, 2025, with 10.24% growth. This brings the company's revenue in the last twelve months to 385.12M, up 3.76% year-over-year. In the year 2024, StemCyte International had annual revenue of 382.69M with 5.49% growth.

Revenue (ttm)
385.12M
Revenue Growth
+3.76%
P/S Ratio
13.63
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.25B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024382.69M19.91M5.49%
Dec 31, 2023362.78M15.09M4.34%
Dec 31, 2022347.69M-509.38M-59.43%
Dec 31, 2013857.07M124.33M16.97%
Dec 31, 2012732.74M205.09M38.87%
Dec 31, 2011 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
INTAI Technology 2.41B
Progate Group 1.35B
Aurona Industries 1.30B
Pharmosa Biopharm 136.72M
OBI Pharma 49.29M
Asia Tech Image 3.71B
VSO Electronics 2.61B
Hye Technology Co.,Ltd 480.58M
Revenue Rankings